Naturally occurring glutamate receptor agonist neurotoxin Ibotenic acid, or ibotenate, also known as premuscimol or as (S)-2-amino-2-(3-hydroxyisoxazol-5-yl)acetic acid, is a naturally occurring α-amino acid found in certain Amanita mushrooms such as Amanita muscaria. It acts primarily as a potent glutamate receptor agonist and produces neurological effects. The compound is used as a brain-lesioning agent in scientific research.
Ibotenic acid is a conformationally-restricted analogue of the excitatory neurotransmitter glutamate which acts as a non-selective agonist of glutamate receptors, strongly activating NMDA, group I and II metabotropic glutamate receptors, and weakly activating AMPA and kainate receptors. Taken systemically, it is a prodrug of muscimol, broken down by the liver into this more stable compound, which acts as a potent GABAA and GABAA-ρ receptor agonist. Although the compound's psychoactive effects are not well-understood, some researchers speculate that ibotenic acid itself may have stimulant-like properties. Ibotenic acid is biosynthesized from glutamic acid by hydroxylation catalyzed by an Fe(II)/2-oxoglutarate-dependent oxygenase, with subsequent conversion steps carried out by enzymes encoded within a linked biosynthetic gene cluster.
Ibotenic acid is commonly used in research to create site-specific hippocampal brain lesions in rats, allowing for task relearning due to its interaction with glutamate receptors, and is favored over other agents for its selectivity and long-term stability in saline solution. It induces excitotoxicity in rodents by overactivating NMDA and metabotropic glutamate receptors, leading to calcium overload and oxidative damage. In contrast, it targets glutamate-gated chloride channels in invertebrates, causing increased chloride permeability without affecting their excitatory glutamate receptors.
Safety at a Glance
High Risk- General Principles
- Start low, go slow: Always begin with a low dose, especially with unfamiliar batches or new substances. Individual se...
- Toxicity: The toxicity and long-term health effects of Ibotenic acid have not been comprehensively studied in scientific litera...
- Overdose risk: Limited specific overdose data is available for Ibotenic acid. In the absence of compound-specifi...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
oral
Duration
oral
Total: 6 hrs – 12 hrsHow It Feels
The onset of ibotenic acid, typically consumed as part of the Amanita muscaria mushroom, is a deeply disorienting process that bears little resemblance to the psychedelic experiences produced by psilocybin or LSD. Within thirty to ninety minutes of ingestion, a profound drowsiness begins to settle over the body, heavy and sedating in a way that feels more like encroaching illness than the beginning of a psychoactive experience. Nausea is common and often severe. There may be excessive salivation, sweating, and a general sense that the body's autonomic systems have been disrupted. Muscle twitching and fasciculations are reported, adding to the sense of physical disquiet.
As the experience deepens, the cognitive effects become apparent, and they are defined above all by confusion. This is not the meaningful confusion of a challenging psychedelic experience where the mind struggles with profound questions. It is a muddled, delirious confusion in which the ordinary organization of thought and perception begins to disintegrate. Spatial awareness becomes unreliable: rooms seem to grow and shrink, objects appear closer or farther than they are, and the sense of the body's position in space becomes precarious. There may be a strange macropsia or micropsia, where objects appear distorted in size, giving the environment an Alice-in-Wonderland quality that is more unsettling than enchanting.
At higher doses, the delirium deepens into a state that can resemble a waking dream. The boundary between internal imagery and external perception becomes porous, and the user may interact with hallucinations as though they were real, holding conversations with people who are not there or responding to events that exist only in the mind. Unlike the visionary content of classical psychedelics, these hallucinations are often mundane, confusing, and devoid of the numinous quality that users of other substances report. There may be periods of apparent lucidity followed by abrupt returns to confused, dreamlike states.
The experience typically lasts four to eight hours, with a prolonged period of grogginess, confusion, and physical discomfort as the effects recede. Sleep, when it arrives, is often heavy and populated with vivid, bizarre dreams. The morning after can bring lingering nausea, headache, and a sense of having been through something unpleasant without having gained anything from the ordeal. The overall character of ibotenic acid intoxication is one of pharmacological disorder, a disruption of normal functioning that lacks the insight, beauty, or emotional richness that makes other altered states sought after.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(6)
- Headache— A painful sensation of pressure, throbbing, or aching in the head that can range from a dull backgro...
- Motor control loss— A distinct decrease in the ability to control one's physical body with precision, balance, and coord...
- Muscle twitching— Muscle twitching consists of small, involuntary, localized contractions or tremors within individual...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
- Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
Cognitive & Perceptual Effects
Cognitive(3)
- Amnesia— A complete or partial inability to form new memories or recall existing ones during and after substa...
- Confusion— An impairment of abstract thinking marked by a persistent inability to grasp or comprehend concepts ...
- Delirium— Delirium is a serious and potentially dangerous state of acute mental confusion involving disorienta...
Auditory(2)
- Auditory distortion— Auditory distortion is the experience of sounds becoming warped, pitch-shifted, flanged, or otherwis...
- Auditory misinterpretation— Auditory misinterpretation is the brief, spontaneous misidentification of real sounds as entirely di...
Pharmacology
The most common symptoms include nausea, vomiting, and drowsiness. However, after the first hour symptoms begin to include confusion, euphoria, visual and auditory distortions, sensations of floating, and retrograde amnesia.
Symptoms are slightly different for children, typically beginning after 30–180 minutes. Dominant symptoms in children include ataxia, obtundation, and lethargy. Seizures are occasionally reported, however, more commonly with children.
Detection Methods
Standard Drug Panel Inclusion
Ibotenic acid is a naturally occurring isoxazole amino acid found in Amanita muscaria and related mushrooms. It is not detected on any standard drug panel. There are no immunoassay channels targeting isoxazole compounds. Ibotenic acid is converted in vivo to muscimol, a potent GABA-A agonist, via decarboxylation.
Urine Detection
Ibotenic acid and muscimol can be detected in urine for approximately 12 to 24 hours after ingestion. Both compounds are excreted renally, with a significant portion of ibotenic acid converted to muscimol before excretion. The short detection window reflects the relatively rapid renal clearance of these small polar molecules.
Blood and Saliva Detection
Blood concentrations of ibotenic acid and muscimol are detectable for approximately 6 to 12 hours. The rapid metabolism and elimination of these compounds limits the blood detection window. Clinical toxicology laboratories can measure these compounds when Amanita mushroom poisoning is suspected.
Hair Follicle Detection
Hair testing for ibotenic acid and muscimol has not been validated and is not available through commercial laboratories. The polar, water-soluble nature of these compounds may limit hair incorporation.
Confirmatory Testing
LC-MS/MS is the preferred method for identifying ibotenic acid and muscimol in biological specimens. These small, polar, amino acid-like compounds require specialized chromatographic methods (HILIC or derivatization) for adequate retention and sensitivity. GC-MS with derivatization is also effective.
Reagent Testing
Standard reagent kits are not designed for ibotenic acid or muscimol testing. Identification of Amanita muscaria mushrooms is typically performed through mycological examination (visual identification of the distinctive red cap with white spots) rather than chemical testing.
Interactions
No documented interactions.
History
Ibotenic acid is a psychoactive substance whose history reflects the broader patterns of drug discovery, use, and regulation that characterize the modern era of psychopharmacology. Detailed historical documentation specific to Ibotenic acid may be limited, particularly for newer research chemicals or less commonly encountered compounds.
Harm Reduction
General Principles
- Start low, go slow: Always begin with a low dose, especially with unfamiliar batches or new substances. Individual sensitivity varies enormously.
- Test your substances: Use reagent test kits to verify identity and check for dangerous adulterants. Consider using drug checking services where available.
- Research thoroughly: Understand expected dose ranges, duration, potential interactions, and contraindications before use.
- Never use alone: Have a trusted, sober person present, especially with new substances or higher doses.
- Set and setting: Your mindset and environment profoundly influence the experience. Choose a safe, comfortable environment and ensure you're in a stable psychological state.
Ibotenic acid-Specific Considerations
As with any psychoactive substance, individual sensitivity to Ibotenic acid can vary significantly. Start with conservative doses, thoroughly research the compound's specific risk profile, and consider the broader context of your physical and mental health before use.
Toxicity & Safety
The toxicity and long-term health effects of Ibotenic acid have not been comprehensively studied in scientific literature. The absence of evidence of harm is not evidence of absence — novel or under-researched substances may carry undocumented risks.
General principles of toxicological concern apply: repeated exposure to any psychoactive substance can lead to neuroadaptive changes, potential organ toxicity, and psychological dependence. The risk profile is influenced by dose, frequency of use, route of administration, individual vulnerability factors, and co-ingested substances.
Given the limited safety data available, extra caution is warranted. Use the lowest effective dose, space sessions widely, and monitor for any adverse physical or psychological changes.
It is strongly recommended that one use harm reduction practices when using this substance.
Overdose Information
Limited specific overdose data is available for Ibotenic acid. In the absence of compound-specific information, general principles apply:
If someone exhibits signs of medical distress after using Ibotenic acid — difficulty breathing, severe confusion, seizures, chest pain, extremely elevated temperature, or loss of consciousness — treat it as a medical emergency. Call emergency services and be forthcoming about what was consumed. Medical professionals follow confidentiality protocols and their priority is saving lives.
Prevention remains the best approach: use the minimum effective dose, avoid combining with other substances, and always have a sober person present who can recognize signs of distress and call for help.
Tolerance
| Full | Limited data — may develop with repeated use |
| Half | Unknown |
| Zero | Unknown |
Cross-tolerances
Legal Status
The legal status of Ibotenic acid varies by jurisdiction and is subject to change. This information is provided for educational purposes and may not reflect the most current legislation.
General patterns: Many psychoactive substances are controlled under national and international drug control frameworks, including the United Nations Single Convention on Narcotic Drugs (1961), the Convention on Psychotropic Substances (1971), and country-specific legislation such as the US Controlled Substances Act, UK Misuse of Drugs Act, and EU Framework Decisions.
Research chemicals and analogues: Novel psychoactive substances may be captured by analogue laws (e.g., the US Federal Analogue Act) or blanket bans on substance classes (e.g., the UK Psychoactive Substances Act 2016), even if the specific compound is not individually scheduled.
Important note: Possessing, distributing, or manufacturing controlled substances carries serious legal consequences in most jurisdictions. Legal status is not a reliable indicator of a substance's safety profile — some highly dangerous substances are legal, while some with favorable safety profiles are strictly controlled.
Users are strongly encouraged to research the specific legal status of Ibotenic acid in their jurisdiction before any involvement with this substance.
Experience Reports (1)
Tips (3)
Clear your schedule for the full duration of Ibotenic acid plus afterglow. Do not plan any obligations, driving, or important decisions for the day. Having a time pressure or commitment hanging over you adds unnecessary anxiety.
Keep a benzodiazepine like alprazolam on hand as an emergency trip abort tool when using Ibotenic acid. Even just knowing you have one available provides psychological reassurance. It will not fully end the trip but significantly reduces intensity.
Start with a low dose of Ibotenic acid if it is your first time. You can always take more next time but you cannot take less once ingested. The difference between a comfortable and an overwhelming experience can be surprisingly small.
See Also
References (3)
- PubChem: Ibotenic acid
PubChem compound page for Ibotenic acid (CID: 1233)
pubchem - Ibotenic acid - TripSit Factsheet
TripSit factsheet for Ibotenic acid
tripsit - Ibotenic acid - Wikipedia
Wikipedia article on Ibotenic acid
wikipedia